Takeda Pharmaceutical Co Ltd (FRA:TKD)
€ 25.61 0.16 (0.63%) Market Cap: 40.44 Bil Enterprise Value: 65.50 Bil PE Ratio: 23.27 PB Ratio: 0.97 GF Score: 82/100

Q3 2020 Takeda Pharmaceutical Co Ltd Earnings Call Transcript

Feb 04, 2020 / 09:00AM GMT
Release Date Price: €36.49 (+3.69%)
Operator

Good day, everyone, and welcome to the conference call of Takeda Pharmaceutical Company Limited. (Operator Instructions)

Now we'll start the conference. Mr. Okubo, please go ahead.

Takashi Okubo
Takeda Pharmaceutical Company Limited - Global Head of IR, Global Finance

[Interpreted] Thank you very much for joining us today despite a very busy schedule for the third quarter earnings call -- conference call.

At today's conference call, I would like to remind everyone that we'll be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 of the United States. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings.

On Page 2, there is some important information. Please refer to this slide as well.

I would like to introduce the presenters and also those who are available to answer your questions today: President and CEO,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot